Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection.

Ripoll E, Pluvinet R, Torras J, Olivar R, Vidal A, Franquesa M, Cassis L, Cruzado JM, Bestard O, Grinyó JM, Aran JM, Herrero-Fresneda I.

Gene Ther. 2011 Oct;18(10):945-52. doi: 10.1038/gt.2011.39. Epub 2011 Apr 7.

PMID:
21472009
[PubMed - indexed for MEDLINE]
2.

Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.

Angin M, Poirier N, Dilek N, Le Guiner C, Toromanoff A, Blancher A, Cherel Y, Deschamps JY, Tillou X, Renaudin K, Minault D, Hervouet J, Blancho G, Vanhove B, Anegon I, Le Mauff B.

Transpl Immunol. 2012 Dec;27(4):139-45. doi: 10.1016/j.trim.2012.10.004. Epub 2012 Oct 23.

PMID:
23098770
[PubMed - indexed for MEDLINE]
3.

[Effect of CD40 blockade on acute renal graft rejection in rats].

Shi XH, Liu XY, Sun XY, Zhao M.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Dec;31(12):2085-6. Chinese.

PMID:
22200719
[PubMed - indexed for MEDLINE]
Free Article
4.

Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.

Shimizu K, Schönbeck U, Mach F, Libby P, Mitchell RN.

J Immunol. 2000 Sep 15;165(6):3506-18.

PMID:
10975872
[PubMed - indexed for MEDLINE]
Free Article
5.

A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.

Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A.

Transplantation. 2002 Jun 15;73(11):1736-42.

PMID:
12084995
[PubMed - indexed for MEDLINE]
6.

CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.

Reul RM, Fang JC, Denton MD, Geehan C, Long C, Mitchell RN, Ganz P, Briscoe DM.

Transplantation. 1997 Dec 27;64(12):1765-74.

PMID:
9422418
[PubMed - indexed for MEDLINE]
7.

CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.

Gaweco AS, Mitchell BL, Lucas BA, McClatchey KD, Van Thiel DH.

Kidney Int. 1999 Apr;55(4):1543-52.

PMID:
10201021
[PubMed - indexed for MEDLINE]
Free Article
8.

STAT-1 decoy oligonucleotide improves microcirculation and reduces acute rejection in allogeneic rat small bowel transplants.

Stojanovic T, Scheele L, Wagner AH, Middel P, Bedke J, Lautenschläger I, Leister I, Panzner S, Hecker M.

Gene Ther. 2007 Jun;14(11):883-90. Epub 2007 Mar 15.

PMID:
17361215
[PubMed - indexed for MEDLINE]
9.

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.

Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.

Transplantation. 2005 Jul 27;80(2):255-63. Erratum in: Transplantation. 2005 Aug 27;80(4):545. Corrected and republished in: Transplantation. 2005 Aug 27;80(4):546-54.

PMID:
16041272
[PubMed - indexed for MEDLINE]
10.

Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients.

Koch M, Mengel M, Poehnert D, Nashan B.

Transplantation. 2007 Feb 27;83(4):498-505.

PMID:
17318083
[PubMed - indexed for MEDLINE]
11.

Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.

Shoker A, George D, Yang H, Baltzan M.

Transplantation. 2000 Aug 15;70(3):497-505.

PMID:
10949194
[PubMed - indexed for MEDLINE]
12.

Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA.

Suzuki M, Zheng X, Zhang X, Li M, Vladau C, Ichim TE, Sun H, Min LR, Garcia B, Min WP.

J Immunol. 2008 Jun 15;180(12):8461-9.

PMID:
18523314
[PubMed - indexed for MEDLINE]
Free Article
13.

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.

Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.

Transplantation. 2005 Aug 27;80(4):546-54.

PMID:
16220623
[PubMed - indexed for MEDLINE]
14.

Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.

Shoker AS, Lun ZR, Choudry R, Saxena A.

Transpl Immunol. 2001 Feb;8(4):219-28.

PMID:
11316064
[PubMed - indexed for MEDLINE]
15.

RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells.

Pluvinet R, Pétriz J, Torras J, Herrero-Fresneda I, Cruzado JM, Grinyó JM, Aran JM.

Blood. 2004 Dec 1;104(12):3642-6. Epub 2004 Aug 17.

PMID:
15315968
[PubMed - indexed for MEDLINE]
Free Article
16.

Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells.

Nathan MJ, Mold JE, Wood SC, Csencsits K, Lu G, Eichwald EJ, Bishop DK.

J Immunol. 2004 Jun 1;172(11):6626-33.

PMID:
15153477
[PubMed - indexed for MEDLINE]
Free Article
17.

Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.

Guillot C, Guillonneau C, Mathieu P, Gerdes CA, Ménoret S, Braudeau C, Tesson L, Renaudin K, Castro MG, Löwenstein PR, Anegon I.

J Immunol. 2002 Feb 15;168(4):1600-9.

PMID:
11823487
[PubMed - indexed for MEDLINE]
Free Article
18.

SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.

Viklický O, Zou H, Müller V, Lacha J, Szabó A, Heemann U.

Transplantation. 2000 Feb 27;69(4):497-502.

PMID:
10708101
[PubMed - indexed for MEDLINE]
19.

The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.

Guillonneau C, Louvet C, Renaudin K, Heslan JM, Heslan M, Tesson L, Vignes C, Guillot C, Choi Y, Turka LA, Cuturi MC, Anegon I, Josien R.

J Immunol. 2004 Feb 1;172(3):1619-29.

PMID:
14734743
[PubMed - indexed for MEDLINE]
Free Article
20.

Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.

Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ, Thomson AW.

Transplantation. 1997 Dec 27;64(12):1808-15.

PMID:
9422424
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk